Benjamin Shaker

This profile gathers the share dealings of Benjamin Shaker in Agilon Health, Inc., where the filings describe the role as senior executive. We count 36 filings; the first trade dates from 14 September 2021 and the latest from 15 April 2026.

Both buying and selling appear: 4 purchases worth €256k, against 7 sales worth €2.5M. The amount is not disclosed for 3 filings. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 10 share grants and 15 option exercises. In 2026 alone, the filings show 2 purchases and no sales.

Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 16 April 2026 came the latest disclosure, a share grant for €13k in Agilon Health, Inc. The latest purchase dates back some time: it was published 221 days ago, on 11 March 2026. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.